+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-07-07Number of Pages: 109

Cytology and HPV Testing Market (Product and Services - Cytology Testing (Systems, Assay Kits, Services), HPV Testing - Systems, Assay Kits, Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Cytology and HPV Testing Market: Snapshot

Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.

The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies, where factors such as rapidly developing healthcare infrastructure and a strong local manufacturing base serve as major advantages. In addition to this, these markets still have immense scope for growth, unlike the near-saturated markets in developed countries.

 

cytology-and-hpv-testing

 

Low-cost Labor in APAC a Major Attraction for Cytology and HPV Testing Cos

The cytology and HPV testing market can be geographically segmented into Europe, North America, Asia Pacific, and Rest of the World. North America is by far the largest market for cytology and HPV testing accounting for a 52.5% share in 2015. This can be attributed to the rising incidence of HPV infections and cervical cancer, the increasing number of awareness programs by government and private organizations, and the availability of technologically advanced diagnostic test kits. The Centers for Disease Control and Prevention states that an estimated 79 million people in the U.S. are infected with HPV, with around 14 million people newly infected each year. Each year, more than 11,000 women in the country are diagnosed with cervical cancer.

The rising adoption of cytology and HPV testing is driven by the same factors as those fueling the North America market. In addition to these, the soaring demand for advanced imaging modalities and sensitive screening tests such as liquid-based cytology are anticipated to further accelerate the Europe market. Germany is the largest contributor to the Europe cytology and HPV testing market owing to the recent introduction and enhancement of various new technologies in the field of diagnostics. Government screening programs have also favorably benefited this regional market.

Emerging as one of the most attractive destinations for cytology and HPV testing as well as for the manufacturing of testing kits and systems, Asia Pacific is anticipated to witness immense growth during the forecast period. Thanks to the availability of low-cost and highly-skilled IT labor, leading companies such as Qiagen N.V. and Hologic Corporation have been setting up shop in APAC to capitalize on the opportunities presented by this region.

Although the RoW segment is also anticipated to witness a rise in the demand for cytology and HPV testing, especially in Africa, the narrow distribution network as well as the low awareness and adoption rate in several underdeveloped regions are likely to hamper market growth.

Modest Growth on the Cards

HPV testing services dominate the HPV testing market, accounting for a whopping 78.2% share in 2015 owing to an increasing number of women undergoing HPV tests for the detection and diagnosis of cervical cancer. Similarly, cytology testing services led the cytology testing market with a 78.7% share in 2015. This is due to the large number of PAP tests performed across the globe.

The soaring incidence of HPV infections and cervical cancer can be attributed to several risk factors, including the weakening of the immune system due to illness and a high number of sexual partners. Technological advancements in healthcare and growing awareness among the general population are also encouraging people to opt for high-accuracy diagnostic tests. Driven by these factors, the HPV testing market is expected to grow from US$7.9 bn in 2015 to US$10.5 bn by 2024 at a 2.9% CAGR therein.

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Global Cytology and HPV Testing Market, Estimates and Forecast, By Revenue, 2014–2024 (US$ Mn)
2.2 Global HPV Testing Market, by Product and Services, 2015 (US$ Mn)
2.3 Global Cytology Testing Market, by Product and Services, 2015 (US$ Mn)
2.4 Global Market Share by Geography, 2015 and 2024 (Value %)
2.5 Cytology and HPV Testing Market Snapshot

Chapter 3 Cytology and HPV Testing Market – Market Analysis 
3.1 Introduction
3.2 Market Drivers
       3.2.1 Rising incidence of cervical cancer worldwide
       3.2.2 High incidence rate of HPV infections
       3.2.3 Increasing cervical cancer screening awareness programs
3.3 Restraints
       3.3.1  Lack of appropriate primary healthcare infrastructure
       3.3.2  Low awareness of the global population hinders the growth of the market
3.4 Opportunity
     3.4.1 Emerging economies to offer sustained growth opportunities
3.5 Market Attractiveness Analysis - Global Cytology and HPV Testing Market
3.6 Porter’s Five Forces Analysis
3.7 Competitive Landscape
       3.7.1 Market Positioning of Key Players
       3.7.2 Competitive Strategies adopted by Key Players
       3.7.3 Recommendations
3.8 Epidemiology: HPV and Cervical Cancer
3.9 Market Segmentation – By Product and Services
       3.9.1 Introduction - HPV Testing Market
       3.9.2 Global HPV Testing Systems Market Revenue, (US$ Mn), 2014–2024
       3.9.3 Global HPV Testing Assay Kits Market Revenue, (US$ Mn), 2014–2024
       3.9.4 Global HPV Testing Services Market Revenue, (US$ Mn), 2014–2024
3.10 Market Segmentation – By Product and Services
       3.10.1 Introduction – Cytology Testing
       3.10.2 Global Cytology Testing Systems Market Revenue, (US$ Mn), 2014–2024
       3.10.3 Global Cytology Testing Assay Kits Market Revenue, (US$ Mn), 2014–2024
       3.10.4 Global Cytology Testing Services Market Revenue, (US$ Mn), 2014–2024

Chapter 4 Market Segmentation – By Region
4.1 North America Cytology and HPV Testing Market Revenue, (US$ Mn), 2014–2024
       4.1.1 U.S. 
       4.1.2 Canada 
4.2 Europe Cytology and HPV Testing Market Revenue, (US$ Mn), 2014–2024
       4.2.1 Germany 
       4.2.2 France 
       4.2.3 U.K. 
4.3 Asia Pacific Cytology and HPV Testing Market Revenue, (US$ Mn), 2014–2024
       4.3.1 Japan 
       4.3.2 China
       4.3.3 Australia
4.4 Rest of the World Cytology and HPV Testing Market Revenue, (US$ Mn), 2014–2024
       4.4.1 Brazil 
       4.4.2 Mexico 
       4.4.3 RoW

Chapter 5 Company Profiles
5.1 Abbott Laboratories, Inc.
       5.1.1 Company Overview
       5.1.2 Financial Overview
       5.1.3 Product Portfolio
       5.1.4  Business Strategies
       5.1.5  Recent Development
5.2 Arbor Vita Corporation
5.3 Becton, Dickinson and Company
5.4 Cepheid, Inc.
5.5 F. Hoffmann-La Roche Ltd.
5.6 Fujirebio Diagnostics, Inc.
5.7 Hologic, Inc.
5.8 OncoHealth Corporation
5.9 QIAGEN N.V

List of Figures
 

FIG. 1 Global Cytology and HPV Testing Market Estimates and Forecast, (US$ Mn), 2014–2024
FIG. 2 Global HPV Testing Market Revenue, by Product and Services, (US$ Mn), 2015
FIG. 3 Global Cytology Testing Market Revenue, by Product and Services, (US$ Mn), 2015
FIG. 4 Global Cytology and HPV Testing Market, by Geography (%), 2015
FIG. 5 Global Cytology and HPV Testing Market, by Geography (%), 2024
FIG. 6 Market Attractiveness Analysis, by Geography (2015)
FIG. 7 Global Cytology Testing Market, by Key Players (%), 2015
FIG. 8 Global HPV Testing Market, by Key Players (%), 2015
FIG. 9 Global HPV Testing Systems Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Global HPV Testing Assay Kits Market Revenue, (US$ Mn), 2014–2024
FIG. 11 Global HPV Testing Services Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Global Cytology Testing Systems Market Revenue, (US$ Mn), 2014–2024
FIG. 13 Global Cytology Testing Assay Kits Market Revenue, (US$ Mn), 2014–2024
FIG. 14 Global Cytology Testing Services Market Revenue, (US$ Mn), 2014–2024
FIG. 15 U.S. Cytology and HPV Testing Market, by Revenue, (US$ Mn), 2014–2024
FIG. 16 Canada Cytology and HPV Testing Market, by Revenue, (US$ Mn), 2014–2024
FIG. 17 Germany Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 18 France Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 19 U.K. Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 20 China Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 21 Japan Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 22 Australia Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 23 Brazil Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 24 Mexico Cytology and HPV Testing Market, (US$ Mn), 2014–2024
FIG. 25 Abbott Laboratories Financial Overview: (US$ Mn) 2013–2015 
FIG. 26 Abbott Laboratories Operating Expenses: (US$ Mn) 2013–2015
FIG. 27 Becton, Dickinson and Company Financial Overview: (US$ Mn) 2013–2015
FIG. 28 Becton, Dickinson and Company Geographic Financial Overview: (US$ Mn), 2013–2015 
FIG. 29 Cepheid, Inc. Financial Overview: (US$ Mn) 2013–2015
FIG. 30 Cepheid, Inc. Geographic Financial Overview: (US$ Mn), 2013–2015
FIG. 31 Cepheid, Inc. Operating Income: (US$ Mn), 2013–2015
FIG. 32 F. Hoffmann-La Roche Ltd Financial Overview: (US$ Mn), 2013–2015
FIG. 33 F. Hoffmann-La Roche Ltd Operating Profit: (US$ Mn) 2013–2015
FIG. 34 Hologic, Inc. Financial Overview: (US$ Mn), 2013–2015
FIG. 35 Hologic, Inc. Geographic Financial Overview: (US$ Mn), 2013–2015
FIG. 36 Hologic, Inc. Operating Income: (US$ Mn), 2013–2015
FIG. 37 QIAGEN N.V. Financial Overview: (US$ Mn), 2013–2015
FIG. 38 QIAGEN N.V. Operation Income Overview: (US$ Mn), 2013–2015

List of Tables

TABLE 1 Cytology and HPV Testing Market Snapshot
TABLE 2 Crude incidence of HPV-related cervical cancer per 100,000 women population
TABLE 3 Global HPV Testing Market Estimates and Forecast, by Product and Services, (US$ Mn), 2014–2024
TABLE 4 Global Cytology Testing Market Estimates and Forecast, by Product and Services, (US$ Mn), 2014–2024
TABLE 5 North America HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 6 North America Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 7 North America Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 8 Europe HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 9 Europe Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 10 Europe Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 11 Asia Pacific HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 12 Asia Pacific Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 13 Asia Pacific Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 14 Rest of the World HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 15 Rest of the World Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014–2024
TABLE 16 Rest of the World Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014–2024

This report on the global cytology and HPV testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global cytology and HPV testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Cytology and HPV testing kits are used extensively in PAP testing and cervical cancer testing. This report on the cytology and HPV testing market analyzes the current and future prospects of the market. An elaborate executive summary includes the market snapshot demonstrating overall information on various segments and sub-segments. This section also provides the complete information and data analysis of the cytology and HPV testing market with respect to the leading market segments based on product and services, and geography.

The market overview section of the report includes qualitative analysis of the overall cytology and HPV testing market including the determining factors and the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis. This section of the report also provides market attractiveness analysis with thorough analysis of the overall competitive scenario in the global overall cytology and HPV testing market. In addition, epidemiology of HPV and cervical cancer has been provided which gives incidence rate, annual number of new cases, and mortality of HPV-related cervical cancer in different countries. The competitive scenario between different market players is evaluated through market share analysis. These factors are anticipated to help the market players to take strategic decisions in order to strengthen their positions and increase their shares in the global market.

The cytology and HPV testing market has been segmented based on product and services, and geography. Furthermore, each type of testing has been categorized into assay kits, systems, and services. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 is provided for all the segments, considering 2015 as the base year.

Geographically, the cytology and HPV testing market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). All the mentioned geographies are analyzed by major countries for cytology and HPV testing. The recommendations section included in the report is likely to assist existing players to increase their market shares and new companies to establish their presence in the cytology and HPV testing market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Key players in the global cytology and HPV Testing market are Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation.

The global cytology and HPV testing market has been segmented as follows:

Global Cytology and HPV Testing Market, by Product and Services

  • Cytology Testing
    • Systems
    • Assay Kits
    • Services
  • HPV Testing
    • Systems
    • Assay Kits
    • Services

Global Cytology and HPV Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • Rest of APAC
  • Rest of the World (RoW)
    • Brazil
    • Mexico
    • Rest of RoW

 


 
 
Back To Top